Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Shares Outstanding (2016 - 2025)

BioCorRx's Shares Outstanding history spans 16 years, with the latest figure at $160000.0 for Q3 2025.

  • For Q3 2025, Shares Outstanding fell 98.57% year-over-year to $160000.0; the TTM value through Sep 2025 reached $160000.0, down 98.57%, while the annual FY2024 figure was $80000.0, 50.0% down from the prior year.
  • Shares Outstanding for Q3 2025 was $20.2 million at BioCorRx, up from $17.3 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $20.2 million in Q3 2025 and bottomed at $80000.0 in Q1 2021.
  • The 5-year median for Shares Outstanding is $160000.0 (2021), against an average of $4.9 million.
  • The largest YoY upside for Shares Outstanding was 21502.36% in 2025 against a maximum downside of 98.57% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $6.7 million in 2021, then tumbled by 97.61% to $160000.0 in 2022, then changed by 0.0% to $160000.0 in 2023, then changed by 0.0% to $160000.0 in 2024, then changed by 0.0% to $160000.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Shares Outstanding are $160000.0 (Q3 2025), $17.3 million (Q2 2025), and $80000.0 (Q1 2025).